MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$11.41 -0.06 (-0.52%)
At close: Oct 2, 2026 · 4:00 PM EDT

MoonLake Immunotherapeutics (MLTX) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

MoonLake Immunotherapeutics (MLTX) recorded Return on Capital Employed [ROCE] of -60.74% in Q2 2026, down 16.91 percentage points from -43.83% a year earlier but up 12.25 percentage points from the prior quarter.

Analysis

MoonLake Immunotherapeutics (MLTX) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, MoonLake Immunotherapeutics reported Return on Capital Employed [ROCE] of -60.35%, down 30.52 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a four-year change of +67.00 percentage points (FY2021 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -29.82% in FY2024 (-11.27 pp), -18.55% in FY2023 (+164.22 pp), -182.77% in FY2022 (-55.42 pp) and -127.35% in FY2021.
  • Quarterly Return on Capital Employed [ROCE] has ranged from -127.33% in Q4 2021 to -10.75% in Q4 2023 over the past five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined for eight consecutive quarters, with an average year-over-year change of -26.28 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 84.77 percentage points in Q1 2024, against a drop of 37.72 percentage points in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -73.00% (Q1 2026), -65.48% (Q4 2025) and -58.94% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 MoonLake Immunotherapeutics 971.07 Mn -698.33 Mn - -60.74%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -60.74%
Mar 31, 2026 -73.00%
Dec 31, 2025 -65.48%
Sep 30, 2025 -58.94%
Jun 30, 2025 -43.83%
Mar 31, 2025 -36.28%
Dec 31, 2024 -30.09%
Sep 30, 2024 -21.22%
Jun 30, 2024 -14.46%
Mar 31, 2024 -11.37%
Dec 31, 2023 -10.75%
Sep 30, 2023 -11.31%
Jun 30, 2023 -20.60%
Mar 31, 2023 -96.14%
Dec 31, 2022 -86.69%
Sep 30, 2022 -71.60%
Jun 30, 2022 -33.63%
Dec 31, 2021 -127.33%
API Access

MoonLake Immunotherapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MLTX&period=max&api_key=YOUR_API_KEY